Cancellations by sponsors

This database shows cancellations of Australian Register of Therapeutic Goods entries requested by sponsors.

Last updated

23 December 2025

Find out more at Information about cancellations requested by the sponsor - regulatory actions.

Filters applied:

2017

Clear all

7409 result(s) found, displaying 6951 to 6975

APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Apotex Pty Ltd
CAFNEA INJECTION Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA INJECTION Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA INJECTION Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA INJECTION Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA Oral Solution Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA Oral Solution Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA Oral Solution Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
CAFNEA Oral Solution Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Integrated Sciences Pty Ltd
Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Integrated Sciences Pty Ltd
Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Integrated Sciences Pty Ltd
Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Integrated Sciences Pty Ltd
Paraldehyde Injection BP Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Paraldehyde Injection BP Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Paraldehyde Injection BP Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Paraldehyde Injection BP Cancelled under s30(1)(c)

10 February 2017

Cancellation by sponsor

Requested by Phebra Pty Ltd
Silver Chain Nursing Association - Telemetry system, electrocardiograph Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Silver Chain Nursing Association
Silver Chain Nursing Association - Telemetry system, electrocardiograph Cancelled under s41GL(d) of the Act

10 February 2017

Cancellation by sponsor

Requested by Silver Chain Nursing Association

Last updated

23 December 2025

Sub menu

Product regulation

Safety and shortages

Resources and guidance

Business services

Cancellations by sponsors

Filter results

Decision type

Date of effect

APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

APOTEX-PREGABALIN pregabalin 75 mg capsule blister pack Cancelled under s30(1)(c)

CAFNEA INJECTION Cancelled under s30(1)(c)

CAFNEA INJECTION Cancelled under s30(1)(c)

CAFNEA INJECTION Cancelled under s30(1)(c)

CAFNEA INJECTION Cancelled under s30(1)(c)

CAFNEA Oral Solution Cancelled under s30(1)(c)

CAFNEA Oral Solution Cancelled under s30(1)(c)

CAFNEA Oral Solution Cancelled under s30(1)(c)

CAFNEA Oral Solution Cancelled under s30(1)(c)

Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

Fluorescein Sodium Injection 10% Cancelled under s30(1)(c)

Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

Integrated Sciences Pty Ltd - Bacterial infectious disease IVDs Cancelled under s41GL(d) of the Act

Paraldehyde Injection BP Cancelled under s30(1)(c)

Paraldehyde Injection BP Cancelled under s30(1)(c)

Paraldehyde Injection BP Cancelled under s30(1)(c)

Paraldehyde Injection BP Cancelled under s30(1)(c)

Silver Chain Nursing Association - Telemetry system, electrocardiograph Cancelled under s41GL(d) of the Act

Silver Chain Nursing Association - Telemetry system, electrocardiograph Cancelled under s41GL(d) of the Act

Is there anything wrong with this page?